Dexcom earnings were $576.2M for the trailing 12 months ending Dec 31, 2024, with 4.3% growth year over year. The latest DXCM earnings report on Dec 31, 2024 announced Q4 2024 earnings of $151.7M, up 12.7% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, DXCM reported annual earnings of $576.2M, with 6.4% growth.
DXCM past earnings growth
How has DXCM's earnings growth performed historically?
On DXCM's earnings call on Invalid Date, Dexcom (NASDAQ: DXCM) reported Q4 2024 earnings per share (EPS) of $0.38, up 42.42% year over year. Total DXCM earnings for the quarter were $151.70 million. In the same quarter last year, Dexcom's earnings per share (EPS) was $0.66.
As of the last Dexcom earnings report, Dexcom is currently profitable. Dexcom's net profit (also called net income) for the twelve months ending Dec 31, 2024 was $576.20 million, a 6.41% increase year over year.
What was DXCM's earnings growth in the past year?
As of Dexcom's earnings date in Invalid Date, Dexcom's earnings has grown 4.29% year over year. This is 44.2 percentage points lower than the US Medical Devices industry earnings growth rate of 48.48%. DXCM earnings in the past year totalled $576.20 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.